Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_assertion type Assertion NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_head.
- NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_assertion description "[Within 12 weeks after administration of MNU, the transgenic mice developed forestomach papillomas and then carcinomas very frequently, at the rate of almost 100% and almost all of the tumors had point mutations in their transgenes at the 12th codon from GGC (Gly) to GAC (Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_provenance.
- NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_assertion evidence source_evidence_literature NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_provenance.
- NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_assertion SIO_000772 1844246 NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_provenance.
- NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_assertion wasDerivedFrom befree-20140225 NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_provenance.
- NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_assertion wasGeneratedBy ECO_0000203 NP209592.RACaFGMvQ2FZ6yhbbvAZ5ieuXCYMQjLgyaXDEmDubDZ_M130_provenance.